Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Developing Drugs for Core Social and Communication Impairment in Autism
HTML
Details
Locations
Year:
2008
Type:
review
Source:
Child and Adolescent Psychiatric Clinics of North America
DOI:
10.1016/j.chc.2008.06.010
Authors:
David J. Posey,
Craig A. Erickson,
Christopher J. McDougle
Institutions:
Riley Hospital for Children,
Christian Sarkine Autism Treatment Center,
Indiana University School of Medicine,
Indiana University – Purdue University Indianapolis
Language:
English
Topic:
Autism Spectrum Disorder Research
Subfield:
Cognitive Neuroscience
Field:
Neuroscience
Domain:
Life Sciences
Keywords:
autism spectrum disorder,
pharmacotherapy,
social dysfunction,
communication disorders,
irritability,
risperidone,
fenfluramine,
naltrexone,
secretin,
selective serotonin reuptake inhibitors,
cholinergic drugs,
glutamatergic drugs,
oxytocin,
social relatedness
show all 14
SDG:
Good health and well-being
Open Access status:
green
Funder:
National Institute of Mental Health
Award:
Psychopharmacology of Autism and related Disorders
OpenAlex ID:
W2011201335
FWCI:
0.5
Cites:
71
Cited by:
65
Related to:
10